Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective studyÉlisa Gobbini, Silvia Novello, Laura Ghilardi et al.|Clinical & Translational Oncology|2019Cited by 5
MA26.02 Upfront or Sequential Strategy for New Generation Anaplastic Lymphoma Kinase (ALK) Inhibitors: An Italian Retrospective Study.Élisa Gobbini, Silvia Novello, Pamela Pizzutilo et al.|Journal of Thoracic Oncology|2018Cited by 1